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on the early events of haemopoiesis, and the factors
that govern them is presented. A detailed
description of methods and protocols for
performance of clonogenic assays for granulocyte-
macrophage progenitor cells is provided, together
with a reasoned discussion of their application to
the study of haemopoietic disorders.
Chapter 6 discusses histochemical reactions of
leukocytes. Illustration of the basic concepts and
details of each reaction are followed by a careful
discussion of their utility for the identification of
the stages of development of normal blood cells,
and in the differential diagnosis of leukaemia.
This is a publication of high quality, beautifully
presented and well referenced. It will serve to
broaden the outlook of haematologists by
illustrating the value that techniques rarely used in
routine work have in arriving at a correct
understanding of leukocyte function.
Lina Matera
Istituto di Medicina Interna,
Universita di Torino,
IA Cattedra di Patologia Speciale Medica,
Turin, Italy.
Biochemical markersfor cancer. Edited by T. MING
CHU. Clinical and Biochemical Analysis, Vol. 11.
Marcel Dekker, New York, 375 pp, £55.35.
The efforts to find tumour markers are very
considerable, although the chances of finding really
specific and sensitive markers for common tumours
still seem to be remote. Unfortunately few of the
tumours where early diagnosis would be strongly in
the patient's interest are associated with
recognisable markers. Conversely so many of the
cancers that are associated with unequivocal rises of
biochemical markers in the blood or urine have
often spread so as to render cure highly
improbable. This book reviews the progress in
finding and defining tumour markers and the
challenge of how to use the knowledge gained so
far, as well as containing the search for markers
which at times becomes like the quest for the Holy
Grail. There are written reviews of CEA, AFP,
alkaline phosphatase and prostatic acid
phosphatase, which with ,BHCG are the anchors in
the tumour marker business. These are supported
by informative chapters on ectopic hormone
production, immunoglobulins, enzymes and
polyamines as tumour markers. The special
techniques for the differential diagnosis of the
leukaemia using biochemical markers and the
present status of hormone receptor protein research
provide excellent material to broaden the base of
the book. Trophoblastic tumours that are the
paradigm for all who seek stochiometric
relationships between numbers of cancer cells and
marker levels are included in the book. Perhaps the
only criticism is the absence of a chapter on
statistics, as mathematical logic used in association
with the present generation of computers can help
to extract more information from the combination
of clinical information and the levels of one or
many analyses. The challenge is clearly to optimize
the information that can be obtained by the
combination of clinical, histological and
biochemical assessment. Despite its omission, this is
a sturdy volume, clearly achieving the editors'
objectives of being up-to-date, informative and
showing some of the ways where progress may be
achieved.
E.H. Cooper
Unit for Cancer Research,
School of Medicine,
Leeds.
New approaches in cancer therapy IL H. CORTES
FUNES & M. ROZENCWEIG, New York, Raven
Press, 185 pp, 1982, $55.80.
This book is a monograph based on a symposium
organised by the European Organisation for the
Research and Treatment of Cancer. It is divided
into two sections, the first is devoted to new anti-
cancer drugs with reviews on the podophyllotoxins,
AMSA and PALA and provides an up-to-date
appraisal of the merits of these drugs. The second
section is devoted to combined modality therapy
and covers all common tumours. Although there
are some informative chapters the majority of the
papers are short and there has unfortunately been
no attempt at a oritical editorial review. This has
led to a variation in style and in a more formal
setting I do not think some of the presentations
would have been accepted as a publication. There
are now several books of this type available and in
view of the cost one must critically look at new
volumes as they appear. The type of material
presented is probably more readily available in the
appropriate journals which contain authoritative
reviews. I am afraid it does not compete at all well
with many similar texts that are currently available.
P.M. Wilkinson
Dept. Clinical Pharmacology,
Christie Hospital & Holt Radium Institute,
Manchester.